Sponsor Pipeline

Atavistik Bio, Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
6
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07601425
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)		 Recruitment opened
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07601425 Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT) Hereditary Hemorrhagic Telangiectasia (HHT) Recruiting
Phase 1
NCT07038369 A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations Advanced Solid Tumors Active, Not Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1) Prostate Cancer (1) Ovarian Cancer (1) Cervical Cancer (1) Endometrial Cancer (1)
Get alerts when Atavistik Bio, Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free